全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1369773-39-6 | (alphaR,gammaS)-gamma-[(3-Carboxy-1-oxopropyl)amino]-alpha-methyl-[1,1'-biphenyl]-4-pentanoic acid 4-ethyl ester calcium salt (2:1);AHU-377 hemicalcium salt | 2(C24H29NO5).Ca |
| 1369852-71-0 | Lotilaner;3-methyl-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-5-[(5S)-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]thiophene-2-carboxamide | C20H14Cl3F6N3O3S |
| 1370025-54-9 | 2-Bromo-6-fluoro-4-methylbenzaldehyde | C8H6BrFO |
| 1370250-39-7 | 3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione;7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | C17H17N3O4 |
| 1370256-78-2 | N-(4-Methylphenyl)-N'-[5-[[7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]thio]-1,3,4-thiadiazol-2-yl]urea | C25H27N7O3S2 |
| 1370261-96-3 | 2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-5-pyrimidinecarboxamide | C19H23N9O |
| 1370261-97-4 | 2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-5-pyrimidinecarboxamide hydrochloride (1:1) | C19H23N9O.HCl |
| 1370287-43-6 | 3-Bromo-7-methylpyrazolo[1,5-a]pyrimidine-6-carboxylic acid ethyl ester | C10H10BrN3O2 |
| 1370290-34-8 | 2-[[4-[4-[[3-[(2-Methyl-6-benzothiazolyl)amino]-3-oxopropyl]amino]-4-oxobutyl]phenyl]methyl]propanedioic acid | C25H27N3O6S |
| 1370347-50-4 | (alphaS)-3,5-Dichloro-alpha-methyl-4-pyridinemethanol;(1S)-1-(3,5-dichloropyridin-4-yl)ethanol | C7H7Cl2NO |
| 1370406-77-1 | (R)-2-Benzyl-N,N-dimethylaziridine-1-sulfonamide | C11H16N2O2S |
| 1370409-28-1 | Saxagliptin hydrochloride hydrate | C18H25N3O2.HCl.H2O |
| 1370411-46-3 | 2-(Methylsulfonyl)-4-pyrimidinecarboxylic acid | C6H6N2O4S |
| 1370411-47-4 | 3-Bromo-5-fluoro-4-methylbenzaldehyde | C8H6BrFO |
| 1370468-36-2 | Elbasvir;MK 8742 | C49H55N9O7 |
| 1370555-65-9 | (9-Phenyl-9H-carbazol-4-yl)boronic acid | C18H14BNO2 |
| 1370587-22-6 | 5-Chloro-4-(trifluoromethyl)-2-pyridinecarboxylic Ethyl Ester | C9H7ClF3NO2 |
| 1370651-20-9 | Ensartinib;6-Amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[4-[[(3R,5S)-3,5-dimethyl-1-piperazinyl]carbonyl]phenyl]-3-pyridazinecarboxamide | C26H27Cl2FN6O3 |
| 1370705-39-7 | 3-(Hydroxymethyl)bicyclo[1.1.1]pentane-1-carbonitrile | C7H9NO |
| 1372540-25-4 | 2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid | C22H22F3N3O3 |
| 1372719-93-1 | (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide | C45H31O4P |
| 1372719-95-3 | (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-tris(1-methylethyl)phenyl]-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide | C47H59O4P |
| 1372775-52-4 | N-[1,1'-Biphenyl]-2-yl-[1,1'-biphenyl]-4-amine | C24H19N |
| 1372778-66-9 | N-[1,1'-Biphenyl]-3-yl-9,9-dimethyl-9H-fluoren-2-amine | C27H23N |
| 1373038-56-2 | Valdecoxib 3'-Sulfonamide Impurity;3-(5-Methyl-4-phenylisoxazol-3-yl)benzenesulfonamide | C16H14N2O3S |
| 1373038-59-5 | 3-[4-[4-(Aminosulfonyl)phenyl]-5-methyl-3-isoxazolyl]benzenesulfonamide | C16H15N3O5S2 |
| 1373038-60-8 | 4-(5-Methyl-3-phenyl-4-isoxazolyl)-N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]benzenesulfonamide | C32H25N3O6S2 |
| 1373154-68-7 | Gibberellic Acid Acetoxymethyl Ester | C22H26O8 |
| 1373215-15-6 | N-[(3R,4S)-3,4-Dihydro-3-[[(methylamino)carbonyl]oxy]-6-[4-(3-oxetanyl)-1-piperazinyl]-2H-1-benzopyran-4-yl]-4-fluorobenzamide | C25H29FN4O5 |
| 1373232-19-9 | (R)-Benzyl 2-methyl-3-oxopiperazine-1-carboxylate | C13H16N2O3 |
| 1373232-22-4 | (2S)-2-Methyl-3-oxo-1-piperazinecarboxylic acid phenylmethyl ester | C13H16N2O3 |
| 1373232-85-9 | 2-Amino-4-carboxybenzeneacetic acid | C9H9NO4 |
| 1373253-20-3 | 4-Imidazolidinone hydrochloride | C3H6N2O.HCl |
| 1373253-28-1 | 4-Oxo-3-piperidinecarbonitrile hydrochloride | C6H8N2O.HCl |
| 1373255-08-3 | (2S)-2-(Aminomethyl)-4-morpholinecarboxylic acid 1,1-dimethylethyl ester ethanedioate (1:1) | C10H20N2O3.C2H2O4 |
| 1373255-09-4 | (S)-4,4-Difluoropyrrolidine-2-carboxylic acid 2,2,2-trifluoroacetate | C5H7F2NO2.C2HF3O2 |
| 1373321-04-0 | 1R-Dapagliflozin;(2R,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol | C21H25ClO6 |
| 1373422-53-7 | N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine | C22H23N5O2 |
| 1373423-53-0 | N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine ethyl ester | C24H27N5O2 |
| 1373503-65-1 | Tert-butyl 3,3-difluoro-4-formylpiperidine-1-carboxylate | C11H17F2NO3 |
| 1373615-35-0 | 1-[4-(5'-Chloro-3,5-dimethyl[2,4'-bipyridin]-2'-yl)-1-piperazinyl]-3-(methylsulfonyl)-1-propanone | C20H25ClN4O3S |
| 1373764-75-0 | 2-(4-Hydroxyphenyl)-1-(1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)ethanone;YH-306 | C19H18N2O2 |
| 1373869-89-6 | (E)-2-(5-(cyanoimino)-1-propylpyrrolidin-2-yl)acetic acid | C10H15N3O2 |
| 1373881-94-7 | 3-Bromo-5-tert-butylphenylboronic acid | C10H14BBrO2 |
| 1374030-19-9 | (11bS)-4-Hydroxy-2,6-bis(4-methoxyphenyl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide | C34H25O6P |
| 1374258-43-1 | 5-Bromo-7-(trifluoromethyl)-1H-indazole | C8H4BrF3N2 |
| 1374328-81-0 | 1-(Trifluoromethyl)-3-cyclopentene-1-carboxylic acid | C7H7F3O2 |
| 1374507-23-9 | N-[3-[[2-Chloro-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]carbamic acid 1,1-dimethylethyl ester | C16H16ClF3N4O2 |
| 1374507-25-1 | N-[3-[[2-Chloro-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-2-propenamide | C14H10ClF3N4O |
| 1374516-07-0 | TUG 891 | C23H21FO3 |